The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: Results of a noninferiority, randomized, phase IIIb trial

  1. Batista, J.E.
  2. Kölbl, H.
  3. Herschorn, S.
  4. Rechberger, T.
  5. Cambronero, J.
  6. Halaska, M.
  7. Coppell, A.
  8. Kaper, M.
  9. Huang, M.
  10. Siddiqui, E.
Revue:
Therapeutic Advances in Urology

ISSN: 1756-2880,  1756-2872

Année de publication: 2015

Volumen: 7

Número: 4

Pages: 167-179

Type: Article

DOI: 10.1177/1756287215589250 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus